InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Miller Ann Calby, Director. Director active across 3 companies, notably INOVIO PHARMACEUTICALS, INC.. Cumulatively, 8 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €121k. Activity tracked since 10 June 2021. The latest transaction was disclosed on 15 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Miller Ann Calby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
2,167 sharesCommon StockSEC:0001055726-25-000039:0
2,166 sharesCommon StockSEC:0001055726-24-000034:0
19,000 sharesCommon StockSEC:0001055726-23-000034:0
18,000 sharesCommon StockSEC:0001055726-22-000037:0
4,273 sharesCommon StockSEC:0001055726-22-000026:0
27,858 shares0COMMON STOCKSEC:0001209191-21-041787:0
12,874 shares@ US$11.4305100.0% of flowCOMMON STOCKSEC:0001209191-21-039897:0
8,700 sharesCommon StockSEC:0001055726-21-000048:0
8 of 8 declarations
About Miller Ann Calby
Ann Calby Miller is a Board Member at INOVIO Pharmaceuticals, Inc. and PUMA Biotechnology, Inc. She brings significant expertise in corporate governance and business strategy. Her role involves overseeing operations and guiding strategic decisions to ensure the growth and sustainability of the companies. Miller is valued for her ability to combine innovation with accountability in the biopharmaceutical sector.
